Hosted on MSN2mon
Goldman Sachs starts coverage on ResMed with "buy" ratingGoldman believes CPAP therapy will coexist with GLP-1 drugs for OSA treatment, supported by clinical data and insurance policies. ResMed's app engagement also indicates strong therapy compliance.
A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive sleep apnea and CPAP therapy. Chief Marketing Officer Katrin ...
This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.
(RTTNews) - Resmed Inc (RMD) Wednesday said it has published a meta analysis in The Lancet Respiratory Medicine showing that CPAP therapy significantly reduces the risk of death for people with ...
Hosted on MSN1mon
ResMed Close To Joining Very Elite Stock GroupPeople who have trouble breathing as they sleep often turn to ResMed, which makes a face-worn breathing apparatus. Its continuous positive airway pressure (CPAP) device saves lives and is driving ...
The Luna TravelPAP is React's newest portable CPAP machine, and it doesn't look like a CPAP at all. In fact, if you were none the wiser, you might think the Luna TravelPAP was a funky new Bluetooth ...
For 35 years, Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to ...
Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results